http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22612541

Outgoing Links

Predicate Object
contentType Clinical Trial|Comparative Study|Journal Article|Randomized Controlled Trial
endingPage 316
issn 0091-2700
1552-4604
issueIdentifier 3
pageRange 305-316
publicationName The Journal of Clinical Pharmacology
startingPage 305
bibliographicCitation Fayer JL, Zannikos PN, Stevens JC, Luo Y, Sidhu R, Kirkesseli S. Lack of correlation between in vitro inhibition of CYP3A-mediated metabolism by a PPAR-gamma agonist and its effect on the clinical pharmacokinetics of midazolam, an in vivo probe of CYP3A activity. J Clin Pharmacol. 2001 Mar;41(3):305–16. doi: 10.1177/00912700122010122. PMID: 11269571.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d87c4a2b890fdc1e5a245ed17e2b8d5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_018b705fe8b56ca2661c1b051855e7b9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74953fa2f2a81f2b9be9327f58efe0fd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_541a2ac602a88b152a1b6e41fd1645f3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f9ec8f0a41679d42acbbe636b4b0fac
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b988452204318d1112318e990365d97d
date 200103
identifier https://doi.org/10.1177/00912700122010122
https://pubmed.ncbi.nlm.nih.gov/11269571
isPartOf https://portal.issn.org/resource/ISSN/0091-2700
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4646
https://portal.issn.org/resource/ISSN/1552-4604
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Lack of correlation between in vitro inhibition of CYP3A-mediated metabolism by a PPAR-gamma agonist and its effect on the clinical pharmacokinetics of midazolam, an in vivo probe of CYP3A activity
discusses http://id.nlm.nih.gov/mesh/M0159612
http://id.nlm.nih.gov/mesh/M0438535
http://id.nlm.nih.gov/mesh/M0013843
http://id.nlm.nih.gov/mesh/M0328768
http://id.nlm.nih.gov/mesh/M0164516
http://id.nlm.nih.gov/mesh/M0029733
http://id.nlm.nih.gov/mesh/M0021788
http://id.nlm.nih.gov/mesh/M0082919
http://id.nlm.nih.gov/mesh/M0021253
http://id.nlm.nih.gov/mesh/M0010768
http://id.nlm.nih.gov/mesh/M0590166
http://id.nlm.nih.gov/mesh/M0018350
http://id.nlm.nih.gov/mesh/M0027373
http://id.nlm.nih.gov/mesh/M0005591
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D014157Q000819
http://id.nlm.nih.gov/mesh/D065607
http://id.nlm.nih.gov/mesh/D018160Q000819
http://id.nlm.nih.gov/mesh/D020024Q000494
http://id.nlm.nih.gov/mesh/D011804Q000494
http://id.nlm.nih.gov/mesh/D008874Q000493
http://id.nlm.nih.gov/mesh/D006899Q000037
http://id.nlm.nih.gov/mesh/D013777Q000494
hasSubjectTerm http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D011804Q000008
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D004334
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D051544
http://id.nlm.nih.gov/mesh/D008862Q000378
http://id.nlm.nih.gov/mesh/D020719Q000097
http://id.nlm.nih.gov/mesh/D006899Q000378
http://id.nlm.nih.gov/mesh/D006207
http://id.nlm.nih.gov/mesh/D004359
http://id.nlm.nih.gov/mesh/D011485
http://id.nlm.nih.gov/mesh/D008874Q000008
http://id.nlm.nih.gov/mesh/D004347Q000502
http://id.nlm.nih.gov/mesh/D013777Q000097
http://id.nlm.nih.gov/mesh/D008862Q000187
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D011804Q000097
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D018592
http://id.nlm.nih.gov/mesh/D008954
http://id.nlm.nih.gov/mesh/D013777Q000008
http://id.nlm.nih.gov/mesh/D003577Q000378
http://id.nlm.nih.gov/mesh/D019540
http://id.nlm.nih.gov/mesh/D008874Q000097
http://id.nlm.nih.gov/mesh/D066298
http://id.nlm.nih.gov/mesh/D020024Q000097
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4192
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_38ca895fb47c55c08b93484274f41182
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3d4216466641a66ae41510cb235ba416

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243587666
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127718929

Total number of triples: 80.